Summary
- Current Price
- As of today, TECH price is $72.12, down -0.24% on
- Current Price All-Time High
- TECH price is currently -46.96% below its historical high of $135.96 set on
- Market Cap
- TECH current market cap is $11B, up +43.81% over the past 365 days
- PE Ratio
- TECH current PE ratio is 103.59
- Revenue
- TECH current annual revenue is $1.22B, up +5.23% year-over-year
- Next Earnings
- The next earnings release for TECH is on
Profile
| Metric | Value |
|---|---|
| Full Name | Bio-Techne Corporation |
| Ticker | NASDAQ: TECH |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | |
| Website | bio-techne.com |
| Employees | 3,100 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $72.12 | |
| Price, 1D Change | -0.24% | |
| Market Cap | $11B | |
| TTM Dividend Yield | 0.44% | |
| PE Ratio | 103.59 | |
| Beta | 0.94 | |
| Revenue | $1.22B | |
| Revenue, 1Y Change | +5.23% | |
| EPS | $0.46 | |
| EPS, 1Y Change | -56.06% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.08 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 4:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $0.46 | |
| EPS Estimate | $1.92 | |
| EPS Est. Change | +317.70% | |
| Revenue | $1.22B | |
| Revenue Estimate | $1.21B | |
| Revenue Est. Change | -0.92% | |
| Current Price | $72.12 | |
| Price Target | $73.00 | - |
| Price Tgt. Change | +1.22% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.78 | $1.05 | -41.27% | |
| $1.91 | $0.46 | -75.92% | |
| $1.92 | N/A | +317.70% | |
| $2.04 | N/A | +344.92% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.16B | $1.16B | -0.02% | |
| $1.22B | $1.22B | +0.11% | |
| $1.21B | N/A | -0.92% | |
| $1.26B | N/A | +3.59% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +43.04% | |
| Price, 3Y | -13.11% | |
| Market Cap, 1Y | +43.81% | |
| Market Cap, 3Y | -14.12% | |
| Revenue, 1Y | +5.23% | |
| Revenue, 3Y | +10.31% | |
| EPS, 1Y | -56.06% | |
| EPS, 3Y | -72.28% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $72.12 | |
| SMA 200 | $59.95 | |
| SMA 50 | $65.21 | |
| EMA 200 | $60.44 | |
| EMA 50 | $66.55 | |
| MACD | $1.65 | |
| Beta | 0.94 | |
| ATR | $0.61 | |
| 14-Day RSI | 71.20 | |
| 10-Day Volatility | 4.59% |
Dividends
| Metric | Value | Date |
|---|---|---|
| Last Paid | $0.08 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 0.44% | |
| Total Dividend | $0.32 | |
| $50.39M | ||
| 68.69% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $1.22B | |
| EPS | $0.46 | |
| Gross Profit | $790.27M | |
| Gross Margin | 64.80% | |
| Operating Income | $102.26M | |
| Operating Margin | 8.38% | |
| Net Income | $73.36M | |
| Net Margin | 6.02% | |
| EBITDA | $212.16M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.18 | |
| 3.46 | ||
| 2.38 | ||
| - | ||
| 9 | ||
| 11.95 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | 103.59 | |
| 9.28 | ||
| 5.39 | ||
| 31.09 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $1.92B | |
| $162.19M | ||
| $2.56B | ||
| $608.30M | ||
| $639.06M | ||
| $175.85M | ||
| Total Debt | $444.06M | |
| $14.10M | ||
| $25.31M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $1.12B | ||
| $688.02M | ||
| $429.36M | ||
| $588.52M | ||
| $109.90M | ||
| $0.00 | ||
| $25.06M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $287.56M | ||
| -$35.18M | ||
| -$253.91M | ||
| Capex | $31.01M | |
| $256.55M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| RBC Capital | → | |
| TD Cowen | → | |
| Benchmark | → | |
| Citigroup | → | |
| William Blair | → | |
| Stephens & Co. | → | |
| Baird | → | |
| Piper Sandler | ||
| Wells Fargo | → | |
| Evercore ISI Group | → |
Analyst sentiment
Institutional ownership
Screeners with TECH
FAQ
- What is the ticker symbol for Bio-Techne Corporation?
- The ticker symbol for Bio-Techne Corporation is NASDAQ:TECH
- Does Bio-Techne Corporation pay dividends?
- Yes, Bio-Techne Corporation pays dividends. The last payment was $0.08, with an ex-dividend date on May 18, 2026
- What sector is Bio-Techne Corporation in?
- Bio-Techne Corporation is in the Healthcare sector
- What industry is Bio-Techne Corporation in?
- Bio-Techne Corporation is in the Biotechnology industry
- What country is Bio-Techne Corporation based in?
- Bio-Techne Corporation is headquartered in United States
- When did Bio-Techne Corporation go public?
- Bio-Techne Corporation initial public offering (IPO) was on February 9, 1989
- Is Bio-Techne Corporation in the S&P 500?
- Yes, Bio-Techne Corporation is included in the S&P 500 index
- Is Bio-Techne Corporation in the NASDAQ 100?
- No, Bio-Techne Corporation is not included in the NASDAQ 100 index
- Is Bio-Techne Corporation in the Dow Jones?
- No, Bio-Techne Corporation is not included in the Dow Jones index
- When was Bio-Techne Corporation last earnings report?
- Bio-Techne Corporation's most recent earnings report was on May 6, 2026
- When does Bio-Techne Corporation report earnings?
- The next expected earnings date for Bio-Techne Corporation is August 12, 2026
Data Sources & References
- TECH Official Website www.bio-techne.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/842023/000155837025011716/0001558370-25-011716-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- TECH Profile on Yahoo Finance finance.yahoo.com/quote/TECH
- TECH Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tech